Abbott Allan OTC team demobilized: Shijiazhuang Group took over?

Recently, it was reported that Abbott completed the demobilization of its adult nutrition brand “Allan” OTC team by December 31, 2016, and laid off nearly 200 people. With the official implementation of the “Regulations on the Registration of Special Medical Formulas” on July 1, 2016, the Chinese special medical food market officially opened, and Abbott laid off employees at this time, causing concern in the industry.

In response, Abbott responded that all ANS products have been packaged for the Shijiazhuang Group, and Abbott will not comment on the adjustment of its own resources by external service providers. The Beijing News reporter noted that in January of this year, Shijiazhuang Group Ouyi and sales company signed a strategic cooperation with Abbott Trade (Shanghai) Co., Ltd. in 2017. Abbott authorized Ouyi and became a national commercial system supplier, the future. The European and Italian sales team will be responsible for improving the sales of Abbott’s adult nutrition products, including ubiquitin, in the pharmacy channel, and expanding product distribution coverage.

雅培全安素OTC团队遣散:石药集团全盘接手?

Shijiazhuang Group Ouyi and the "all-in-one"

According to public information, Abbott Quanansu is part of Abbott Laboratories and entered China in August 2014. The product is positioned as a nutritional supplement for nutritional supplements for post-operative rehabilitation patients and sub-health populations. Before the official implementation of the “Regulations on the Registration of Formula Foods”, China’s few “special medical formula foods” were the adult nutrition products that Abbott was pushing in the Chinese market.

At present, there are two versions of Allianz layoffs. One is that Abbott currently packages all of Abbott’s products, such as Abbott’s nutritional products, pharmaceuticals, and medical devices, in China, to Shijiazhuang Group. Working with its own “Ouyihe” team, it disbanded the Abbott operations team that previously included Quan'an. According to another statement, Abbott Quan'an has been adopting sales outsourcing measures in China, and due to unsatisfactory sales performance, it failed to meet Abbott’s expectations. Abbott recently outsourced the product sales to the Shijiazhuang Group. Ouyi and the team, the latter disbanded the previous Abbott All-Ansle sales outsourcing team.

For these two statements, Abbott did not respond to the Beijing News reporter, only said that the news of the European Union and the release of the news, said that this is the news of both sides.

Recently, Shijiazhuang Group Ouyi and the sales company announced that Ouyi and Abbott Trade (Shanghai) Co., Ltd. signed a strategic cooperation agreement for 2017. Chen Haixiang, general manager of Shijiazhuang Group Ouyi and sales company, said that this time and Abbott Cooperation, "We are very optimistic about these two cooperative products, in addition to the health food Yilijia SR for diabetes management, the other is the special medical use formula food."

The prospect of cooperation between Quanansu and Ouyihe remains to be seen

China's mainland special medical food market has great potential. According to statistics from the China Nutrition and Health Food Association, China's special medical food consumption accounts for only 1% of the global market, about 600 million yuan, far from meeting market demand. Teng Jiacai, deputy director of the State Food and Drug Administration, also pointed out that the nutritional support of inpatients in hospitals above designated size in China is obviously insufficient. The lack of nutritional support for non-hospital patients and small and medium-sized cities and the rural population. prominent.

According to the European and Italian parties, in terms of sales structure, this year, Ouyi will provide value-added services around key cooperative customers and chain pharmacies. It will build a comprehensive nutrition and health center in many chain pharmacies, using two products including Abbott. More products within, to build value-added services for chronically ill patients.

Palm Ultrasound Series

Specifications:
Display size: 7 inch TFT
Scanning manner: Electronic convex array, electronic linear array
Working frequency: 2.0MHz~10MHz
Display mode: B, B+B, B+M, M, 4B
Scanning range: Convex array 60°~150°
Amplification factor:1.0, 1.2, 1.5,2.0
Gain control: 8 segments TGC and overall gain can be adjusted respectively
Image processing: 8 γ corrections, frame correlation, point correlation, line correlation, digital filtering, digital edge enhancement and pseudo color processing, etc
Image gray-scale: 256 levels
Scanning line number: 512 lines/frame
Frame rate: 30 frames/second
Digital scanning conversion: 512×512×8 bits
Memory capacity: ≥2GB
Conventional measurements: distance, perimeter, area, volume
Obstetric measurement: horses, cattle, sheep, dogs, cats obstetric measurement
Report function: auto make report
Battery capacity: 3000mAH/7.4V,can work more than 2 hours
Display screen: 7" TFT
Output interface: USB port, video.
Overall size: 216mm×147mm×27mm
Total weight: 950g(with battery)
Waterproof: IP65(optional)
Standard Configuration:
Host, convex probe, built-in battery, power adapter, bag.
Optional:
Linear probe, Micro-convex probe, Rectal probe, Backfat probe.

Palm Ultrasound Series,Palm Ultrasound Scanner For Vet,Healthcare Handheld Ultrasound System,Handheld Ultrasound Iphone

Guangzhou Sonostar Technologies Co., Limited , https://www.sonoeye.com

Posted on